- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hangzhou Tigermed Consulting (300347)
Hangzhou Tigermed Consulting stock price live, this page displays SZ 300347 stock exchange data. View the 300347 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hangzhou Tigermed Consulting real time stock price chart below.
What Is the Hangzhou Tigermed Consulting Stock Price Today?
The Hangzhou Tigermed Consulting stock price today is 60.00.
What Is the Stock Symbol for Hangzhou Tigermed Consulting?
The stock symbol for Hangzhou Tigermed Consulting is ""300347.""
What Stock Exchange Does Hangzhou Tigermed Consulting Trade On?
Hangzhou Tigermed Consulting is listed and trades on the Shenzhen stock exchange.
Is Hangzhou Tigermed Consulting a Good Stock to Buy?
Determining whether Hangzhou Tigermed Consulting—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300347 quote. (ISIN: CNE100001KV8)
What Is the Hangzhou Tigermed Consulting Stock Price Today?
The Hangzhou Tigermed Consulting stock price today is 60.00.
What Is the Stock Symbol for Hangzhou Tigermed Consulting?
The stock symbol for Hangzhou Tigermed Consulting is ""300347.""
What Stock Exchange Does Hangzhou Tigermed Consulting Trade On?
Hangzhou Tigermed Consulting is listed and trades on the Shenzhen stock exchange.
Is Hangzhou Tigermed Consulting a Good Stock to Buy?
Determining whether Hangzhou Tigermed Consulting—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300347 quote. (ISIN: CNE100001KV8)
60.00
+2.42(+4.20%)
Closed·
Fair Value
An estimate of a Hangzhou Tigermed Consulting's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57.20
60.46
52 wk Range
41.61
82.79
300347 Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
300347 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Hangzhou Tigermed Consulting's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
57.2060.46
52 wk Range
41.6182.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.52%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.52%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300347 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hangzhou Tigermed Consulting's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
56.55
Downside
-5.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Hangzhou Tigermed Consulting Company Profile
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. It operates through Clinical Trial Solutions; and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. In addition, the company offers patient recruitment, investment management, medical registration, pharmaceuticals and regulations consulting, drug safety, bioequivalence, and third-party training services, as well as chemistry, management, and controls services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
Compare 300347 to Peers and Sector
Metrics to compare | 300347 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300347PeersSector | |
|---|---|---|---|---|
P/E Ratio | 147.8x | 49.7x | −0.5x | |
PEG Ratio | −1.85 | 0.07 | 0.00 | |
Price/Book | 2.4x | 3.8x | 2.6x | |
Price / LTM Sales | 7.6x | 5.5x | 3.2x | |
Upside (Analyst Target) | −1.7% | −2.1% | 41.9% | |
Fair Value Upside | Unlock | 4.8% | 4.3% | Unlock |
Analyst Ratings
14 Buy
4 Hold
2 Sell
Ratings:
20 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 56.55
(-5.75% Downside)
Earnings
Latest Release
Apr 28, 2025
EPS / Forecast
0.19 / 0.325
Revenue / Forecast
1.56B / 1.69B
People Also Watch
FAQ
What Stock Exchange Does Hangzhou Tigermed Consulting Trade On?
Hangzhou Tigermed Consulting is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Hangzhou Tigermed Consulting?
The stock symbol for Hangzhou Tigermed Consulting is "300347."
What Is the Hangzhou Tigermed Consulting Market Cap?
As of today, Hangzhou Tigermed Consulting market cap is 51.31B.
What Is Hangzhou Tigermed Consulting's Earnings Per Share (TTM)?
The Hangzhou Tigermed Consulting EPS (TTM) is 0.39.
When Is the Next Hangzhou Tigermed Consulting Earnings Date?
Hangzhou Tigermed Consulting will release its next earnings report on 24 Aug 2025.
From a Technical Analysis Perspective, Is 300347 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Hangzhou Tigermed Consulting Stock Split?
Hangzhou Tigermed Consulting has split 4 times.
How Many Employees Does Hangzhou Tigermed Consulting Have?
Hangzhou Tigermed Consulting has 10185 employees.
What is the current trading status of Hangzhou Tigermed Consulting (300347)?
As of 24 Jul 2025, Hangzhou Tigermed Consulting (300347) is trading at a price of 60.00, with a previous close of 57.58. The stock has fluctuated within a day range of 57.20 to 60.46, while its 52-week range spans from 41.61 to 82.79.
What Is Hangzhou Tigermed Consulting (300347) Price Target According to Analysts?
The average 12-month price target for Hangzhou Tigermed Consulting is CNY56.54923, with a high estimate of CNY80 and a low estimate of CNY26. 14 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an -5.75% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.